Jing L. Marantz - 09 Jun 2025 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Director
Signature: /s/ Ilan Katz, attorney-in-fact
Issuer symbol: ARCT
Transactions as of: 09 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Jun 2025, 20:00:54 UTC
Previous filing: 12 Mar 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Marantz Jing L.	Director	C/O ARCTURUS THERAPEUTICS HOLDINGS INC., 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO	/s/ Ilan Katz, attorney-in-fact	11 Jun 2025	0001834528

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARCT	Stock option (right to buy)	Award	$0	+15,000		$0.000000	15,000	09 Jun 2025	Common Stock	15,000	$12.54	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares underlying the option vest monthly over a one year period from the date of grant. This represents the 2025 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer.